In summary, our results suggest that isoscopoletin plays an anti-cancer role by regulating glycolysis-related proteins GPD2, GPI, Hsp90α and PGK2, and then inhibiting the glycolysis process and proliferation of tumor cells. This evidence concerns the gene GPI and neoplasm.